Top Markets
Coin of the day
UnicoCell Biomed Co., Ltd. UnicoCell Biomed Co., Ltd.

UnicoCell Biomed Co., Ltd.

6794
Rank in Stocks #19718
UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the... UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.
Share Price
$2.40
Last synced: 2026-08-25
Market Cap
$152.78M
Change (1 day)
0.67%
Change (1 year)
-4.09%
Country
TW
Trade UnicoCell Biomed Co., Ltd. (6794)

Category

EPS for UnicoCell Biomed Co., Ltd. (6794)
EPS as of 2026 TTM: 0
According to UnicoCell Biomed Co., Ltd. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for UnicoCell Biomed Co., Ltd. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH